Fortress Biotech, Inc. (FBIO)
3.65
+0.07
(+1.96%)
USD |
NASDAQ |
Dec 30, 11:12
Fortress Biotech EPS Diluted (Quarterly): 0.111 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Journey Medical Corp. | -0.0928 |
| Ultragenyx Pharmaceutical, Inc. | -1.808 |
| Axsome Therapeutics, Inc. | -0.9442 |
| Apellis Pharmaceuticals, Inc. | 1.658 |
| Absci Corp. | -0.1997 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 8.827M |
| Revenue (Quarterly) | 17.63M |
| Total Expenses (Quarterly) | 11.78M |
| Enterprise Value | 102.52M |
| Gross Profit Margin (Quarterly) | 60.80% |
| Profit Margin (Quarterly) | 50.07% |
| Earnings Yield | -7.33% |
| Normalized Earnings Yield | -9.447 |